PMID- 2257742 OWN - NLM STAT- MEDLINE DCOM- 19910131 LR - 20190824 IS - 0010-7824 (Print) IS - 0010-7824 (Linking) VI - 42 IP - 4 DP - 1990 Oct TI - A pharmacodynamic and pharmacokinetic study of the Chinese No. 1 pill. PG - 439-53 AB - A pharmacodynamic and pharmacokinetic study of the Chinese No. 1 pill, a combined oral contraceptive containing 35 micrograms ethynyloestradiol (EE) and 600 micrograms norethisterone (NET), was performed in 29 women over a period of six months. Blood samples for analysis were taken during a pretreatment cycle, the first and 6th treatment cycles and post-treatment. Minor changes in carbohydrate metabolism occurred and these were particularly noticeable when the incremental areas under the serum concentration-time curves for both glucose and insulin in response to a glucose tolerance test were calculated. No changes occurred in the serum glycosylated haemoglobin levels. The serum concentrations of all the lipids measured (total cholesterol, triglycerides, LDL-C, HDL-C and apolipoproteins AI, AII and B) were significantly increased on treatment as were levels of Factor X, SHBG and caeruloplasmin whereas antithrombin III decreased. In 38 of the 40 treatment cycles, ovulation was suppressed. In one cycle serum oestradiol and progesterone levels showed a typical ovulatory pattern and in another there was evidence of follicular activity without ovulation. Serum EE concentrations showed a similar pattern in both treatment cycles showing that co-administration of NET did not affect EE metabolism. Serum NET levels were higher in the 6th than in the first treatment cycles. On comparing pharmacodynamic and pharmacokinetic parameters, the only statistically significant correlations were between the percentage change in triglycerides and SHBG and serum NET, but not EE concentrations, and between apolipoproteins AI and serum EE. FAU - Chen, J K AU - Chen JK AD - Institute of Planned Parenthood Research, Shanghai, China. FAU - Song, S AU - Song S FAU - Yang, P J AU - Yang PJ FAU - He, M L AU - He ML FAU - Fan, S B AU - Fan SB FAU - Li, L M AU - Li LM FAU - Gui, Y L AU - Gui YL FAU - Fotherby, K AU - Fotherby K LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Contraception JT - Contraception JID - 0234361 RN - 0 (Apolipoproteins) RN - 0 (Contraceptives, Oral, Combined) RN - 0 (Insulin) RN - 0 (Sex Hormone-Binding Globulin) RN - 423D2T571U (Ethinyl Estradiol) RN - 4G7DS2Q64Y (Progesterone) RN - 4TI98Z838E (Estradiol) RN - 9000-94-6 (Antithrombin III) RN - 9001-29-0 (Factor X) RN - 97C5T2UQ7J (Cholesterol) RN - EC 1.16.3.1 (Ceruloplasmin) RN - IY9XDZ35W2 (Glucose) RN - T18F433X4S (Norethindrone) SB - IM MH - Adult MH - Antithrombin III/chemistry MH - Apolipoproteins/blood MH - Ceruloplasmin/chemistry MH - Cholesterol/blood MH - Contraceptives, Oral, Combined/*pharmacokinetics MH - Estradiol/blood MH - Ethinyl Estradiol/*pharmacokinetics MH - Factor X/chemistry MH - Female MH - Glucose/metabolism MH - Humans MH - Insulin/blood MH - Norethindrone/*pharmacokinetics MH - Progesterone/blood MH - Sex Hormone-Binding Globulin/chemistry OID - PIP: 063903 OID - POP: 00198646 OTO - PIP OT - Asia OT - Biology OT - *Carbohydrate Metabolic Effects OT - China OT - Contraception OT - Contraceptive Methods--pharmacodynamics OT - Contraceptive Usage OT - Developing Countries OT - Eastern Asia OT - Endocrine System OT - *Estradiol--analysis OT - Estrogens OT - Examinations And Diagnoses OT - Family Planning OT - *Glucose Metabolism Effects OT - *Hormones--analysis OT - *Laboratory Examinations And Diagnoses OT - Metabolic Effects OT - *Method Acceptability OT - *Oral Contraceptives--pharmacodynamics OT - Physiology OT - Progestational Hormones OT - *Progesterone--analysis OT - *Steroid Metabolic Effects GN - PIP: TJ: CONTRACEPTION. EDAT- 1990/10/01 00:00 MHDA- 1990/10/01 00:01 CRDT- 1990/10/01 00:00 PHST- 1990/10/01 00:00 [pubmed] PHST- 1990/10/01 00:01 [medline] PHST- 1990/10/01 00:00 [entrez] AID - 0010-7824(90)90051-V [pii] AID - 10.1016/0010-7824(90)90051-v [doi] PST - ppublish SO - Contraception. 1990 Oct;42(4):439-53. doi: 10.1016/0010-7824(90)90051-v.